Vivimed Labs Ltd.
NSE: VIVIMEDLAB | BSE: 532660
₹6.32
₹-0.27
(-4.10%)
As on 18-May-2026 15:44IST
Market cap
₹52 Cr
Revenue (TTM)
₹84 Cr
P/E Ratio
--
P/B Ratio
-0.5
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹-35 Cr
-
ROE
0 %
-
ROCE
-9.1 %
-
Industry P/E
57.91
-
EV/EBITDA
-44.3
-
Debt to Equity
-5.1
-
Book Value
₹-12.4
-
EPS
₹-4.2
-
Face value
2
-
Shares outstanding
82,913,915
10 Years Aggregate
CFO
₹1,339.60 Cr
EBITDA
₹794.79 Cr
Net Profit
₹-223.49 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Vivimed Labs
| -64.2 | -18.5 | -11.1 | -- | 1.5 | -27.3 | -22.8 |
|
BSE Healthcare
| 8.9 | 8.8 | 9.5 | 11.4 | 27.0 | 14.4 | 11.8 |
|
Company
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
2016
|
|---|---|---|---|---|---|---|---|
|
Vivimed Labs
| -49.5 | 18.6 | 43.3 | -66.3 | -65.3 | 16.1 | 1.0 |
|
BSE Small Cap
| -1.8 | 62.8 | 32.1 | -6.8 | -23.4 | 59.6 | 1.8 |
|
BSE Healthcare
| -12.1 | 20.9 | 61.4 | -3.5 | -5.9 | 0.5 | -12.9 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Vivimed Labs
|
6.3 | 52.2 | 83.6 | -35.0 | -41.5 | -- | -- | -0.5 |
| 2,799.1 | 23,046.7 | 1,339.4 | 356.4 | 33.2 | 23.2 | 64.7 | 13.9 | |
| 428.1 | 16,146.3 | 2,268.6 | 150.1 | 10.6 | 5.4 | 90.1 | 4.1 | |
| 731.5 | 17,965.3 | 5,365.6 | 595.0 | 16.6 | 13.3 | 30.2 | 3.5 | |
| 1,009.8 | 15,862.8 | 7,918.4 | 429.9 | 10.7 | 7.2 | 36.7 | 2.4 | |
| 1,165.6 | 20,939.7 | 4,560.2 | 1,544.6 | 35.1 | 19.2 | 13.4 | 2.4 | |
| 1,811.3 | 21,167.1 | 1,421.6 | -73.8 | 1.8 | -1.1 | -- | 3.6 | |
| 175.1 | 23,095.7 | 8,869.1 | -383.1 | 1.0 | -4.2 | -- | 2.8 | |
| 466.3 | 18,730.3 | 3,738.7 | 316.7 | 12.5 | 7.5 | 59.1 | 3.9 | |
| 1,571.5 | 25,343.1 | 3,373.0 | 199.0 | 12.6 | 5.9 | 119 | 5.1 |
Shareholding Pattern
View DetailsNews & Analysis
All News
2 min read•By Research Desk
About Vivimed Labs
Vivimed Labs Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients (APIs), finished dosage formulations, specialty chemicals, and retail branded formulations in India. It operates in two segments,... Speciality Chemicals Business and Pharma Business. The company provides APIs and intermediates to generic and ethical companies; and branded formulations in therapeutic segments, such as ophthalmic, nutraceuticals, dermatology, and pain, as well as contract manufacturing of capsules and tablets, syrups and liquids, and nasal sprays and ointments. It also offers active ingredients primarily for hair dye and photochromic applications. Additionally, the company manufactures Favulous tablets for the treatment of mild to moderate cases of Covid-19. Its products are used in home, personal, and industrial care segments. The company also exports its products. The company was incorporated in 1988 and is based in Hyderabad, India. Read more
-
Incorporated
1988
-
Chairman
Manohar Rao Varalwar
-
Managing Director
Santosh Varalwar
-
Headquarters
Bidar, Karnataka
-
Website
Looking for more details about Vivimed Labs Ltd.’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Quarterly Updates
Annual Reports
Announcements
View AnnouncementsBoard Meeting Intimation for Audited Results
17-May-2026No News & Announcements are available.
FAQs for Vivimed Labs
What is the current share price of Vivimed Labs Ltd Today?
The share price of Vivimed Labs Ltd is ₹6.32 (NSE) and ₹6.31 (BSE) as of 18-May-2026 15:44 IST. Vivimed Labs Ltd has given a return of 1.47% in the last 3 years.
What is the current PB & PE ratio of Vivimed Labs Ltd?
Since, TTM earnings of Vivimed Labs Ltd is negative, P/E ratio is not available.
The P/B ratio of Vivimed Labs Ltd is -0.51 times as on 18-May-2026, a 114 discount to its peers’ median range of 3.61 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
0.00
|
0.00
|
|
2024
|
0.00
|
0.00
|
|
2023
|
0.00
|
38.89
|
|
2022
|
0.00
|
0.37
|
|
2021
|
0.00
|
0.33
|
What is the 52 Week High and Low of Vivimed Labs Ltd?
The 52-week high and low of Vivimed Labs Ltd are Rs 29.40 and Rs 5.15 as of 18-May-2026.
What is the market cap of Vivimed Labs Ltd?
Vivimed Labs Ltd has a market capitalisation of ₹ 52 Cr as on 18-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Vivimed Labs Ltd?
Before investing in Vivimed Labs Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.